metformin has been researched along with Arteriovenous Malformations in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Arteriovenous Malformations: Abnormal formation of blood vessels that shunt arterial blood directly into veins without passing through the CAPILLARIES. They usually are crooked, dilated, and with thick vessel walls. A common type is the congenital arteriovenous fistula. The lack of blood flow and oxygen in the capillaries can lead to tissue damage in the affected areas.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lacout, A | 1 |
| Marcy, PY | 1 |
| El Hajjam, M | 1 |
| Lacombe, P | 1 |
1 other study available for metformin and Arteriovenous Malformations
| Article | Year |
|---|---|
Metformin as possible therapy of pulmonary arterio venous malformation in HHT patients.
Topics: Arteriovenous Malformations; Humans; Metformin; Oxidative Stress; Telangiectasia, Hereditary Hemorrh | 2015 |